AIM: The purpose of this study is to study the practice of sedation by Portuguese palliative care teams. METHODS: The teams included on the website of the Portuguese Association for Palliative Care were invited to participate. Data from all the patients sedated between April and June 2010 were recorded. Sedation was defined as the intentional administration of sedative drugs for symptom control, except insomnia, independently of the consciousness level reached. RESULTS: Of the 19 teams invited only 4 actually participated. During the study period, 181 patients were treated: 171 (94 %) were cancer patients and 10 non-cancer patients. Twenty-seven (16 %) patients were sedated: 13 intermittently, 11 continuously, and 3 intermittently at first then continuously. The rate of sedation varied substantially among the teams. Delirium was the most frequent reason for sedation. Midazolam was the drug used in most cases. In 21 cases of sedation, the decision was made unilaterally by the professionals; in 16 (76 %) of those, the situation was deemed to be emergent. From the patients on continuous sedation, 9 (64 %) patients maintained oxygen, 13 (93 %) hydration, and 6 (43 %) nutrition. Two patients who had undergone intermittent sedation were discharged home and one was transferred to another institution; the reason for sedation in the three cases was delirium. CONCLUSION: There is a substantial variation in the sedation rate among the teams. One of the most important aspects was the decision-making process which should be object of reflection and discussion in the teams.
AIM: The purpose of this study is to study the practice of sedation by Portuguese palliative care teams. METHODS: The teams included on the website of the Portuguese Association for Palliative Care were invited to participate. Data from all the patients sedated between April and June 2010 were recorded. Sedation was defined as the intentional administration of sedative drugs for symptom control, except insomnia, independently of the consciousness level reached. RESULTS: Of the 19 teams invited only 4 actually participated. During the study period, 181 patients were treated: 171 (94 %) were cancerpatients and 10 non-cancerpatients. Twenty-seven (16 %) patients were sedated: 13 intermittently, 11 continuously, and 3 intermittently at first then continuously. The rate of sedation varied substantially among the teams. Delirium was the most frequent reason for sedation. Midazolam was the drug used in most cases. In 21 cases of sedation, the decision was made unilaterally by the professionals; in 16 (76 %) of those, the situation was deemed to be emergent. From the patients on continuous sedation, 9 (64 %) patients maintained oxygen, 13 (93 %) hydration, and 6 (43 %) nutrition. Two patients who had undergone intermittent sedation were discharged home and one was transferred to another institution; the reason for sedation in the three cases was delirium. CONCLUSION: There is a substantial variation in the sedation rate among the teams. One of the most important aspects was the decision-making process which should be object of reflection and discussion in the teams.
Authors: R P B Reuzel; G J Hasselaar; K C P Vissers; G J van der Wilt; J M M Groenewoud; B J P Crul Journal: Palliat Med Date: 2008-07 Impact factor: 4.762
Authors: M Maltoni; C Pittureri; E Scarpi; L Piccinini; F Martini; P Turci; L Montanari; O Nanni; D Amadori Journal: Ann Oncol Date: 2009-07 Impact factor: 32.976
Authors: Jeroen G J Hasselaar; Rob P B Reuzel; Stans C A H H V M Verhagen; Alexander de Graeff; Kris C P Vissers; Ben J P Crul Journal: Arch Intern Med Date: 2007-06-11
Authors: Ferraz Gonçalves; Ana Almeida; Catarina Antunes; Maria Cardoso; Margarida Carvalho; Maria Claro; Francisca Coimbra; Inês Diniz; Bruno Fonseca; Emília Fradique; Edna Gonçalves; Florbela Gonçalves; Maria Gonçalves; Américo Magalhães; Paulo Pina; Conceição Pires; Paula Silva; Ricardo Silva; Rui Silva; Filipa Tavares; Laura Teixeira Journal: Support Care Cancer Date: 2013-02-26 Impact factor: 3.603
Authors: Philipp R Klosa; Carsten Klein; Maria Heckel; Alexandra C Bronnhuber; Christoph Ostgathe; Stephanie Stiel Journal: Support Care Cancer Date: 2014-04-18 Impact factor: 3.603
Authors: Santiago Parra Palacio; Clara Elisa Giraldo Hoyos; Camilo Arias Rodríguez; Daniel Mejía Arrieta; John Jairo Vargas Gómez; Alicia Krikorian Journal: Support Care Cancer Date: 2018-03-29 Impact factor: 3.603
Authors: Alawi Luetz; Felix Balzer; Finn M Radtke; Christina Jones; Giuseppe Citerio; Bernhard Walder; Bjoern Weiss; Klaus-Dieter Wernecke; Claudia Spies Journal: PLoS One Date: 2014-11-14 Impact factor: 3.240
Authors: Anna-Maria Krooupa; Bella Vivat; Stephen McKeever; Elena Marcus; Joseph Sawyer; Paddy Stone Journal: Palliat Med Date: 2019-08-22 Impact factor: 5.713